Angel Guan is a PhD student at Melanoma Institute Australia. Get to know Angel in and out of the lab as she answers questions about herself and her latest work.

Can you summarise your latest research?

My current research focuses on uncovering cancer and immune vulnerabilities in Stage III melanoma patients undergoing neoadjuvant therapy. As a PhD student, I am building skills in single-cell data analysis and integrative multi-omics approaches — such as combining spatial and non-spatial single-cell data — to address complex biological questions.

How did you get into melanoma research?

During my Honours year in biochemistry, I investigated the T-lymphocyte-specific protein Lck, which sparked my interest in T cells and cancer immunotherapy. After completing that project, I knew I wanted to shift toward a more immunotherapy-focused path. To support that transition, I took a gap year to explore my interests and eventually completed an internship in a melanoma immunotherapy lab at the University of Auckland — my undergraduate institution.

What is your favourite part of your work?

I enjoy chatting with colleagues from diverse backgrounds. These interactions are not only a great way to keep learning, but they also often spark new ideas.

Do you have any future career goals?

I aim to build a skill set that will enable me to contribute meaningfully to the optimisation of immunotherapy treatments.

Describe yourself in one word:

Positive.

What is your favourite quote?

“A journey of a thousand miles begins with a single step.” — Laozi, Tao Te Ching.

I don’t always see the end of the journey, but this quote reminds me that consistent effort accumulates over time — and that through patience and persistence, transformation quietly emerges.

What is a book you’ve enjoyed recently?

The Book of Eels — Patrik Svensson.